See below for a listing of the WDI Healthcare Research Initiative's latest news and publications.  

recent Media MENTIONS:

• Financial Times, Nov 30, 2011 "Global Fund: reform needed to regain credibility"
• Nature Medicine, October 2011 “Cheap drugs pulled despite wealth gap in middle-income countries”
• Financial Times, Sep 27, 2011 “Tiered pricing opens new markets to pharmas” (Registration may be required)

 PAST MEDIA MENTIONS:

• Nature, January 2010 “Better forecasting urged to avoid drug waste”

• Global Health, January 2010 “In-Country Supply Chains”

• The Economist, January 7^th, 2010 “A spoonful of ingenuity: New ideas for raising money for medical care – and spending it”

• The Economist, April 19^th, 2009

• The Economist, May 15^th, 2008 “Quagmire to goldmine? The rapid growth in developing countries prompts a rethink by drug companies”

• The Economist, November 1^st, 2007 “Money v. Mosquito: Will an ambitious plan to subsidize anti-malarial pills work?”

• Homeland Protection Professional, March 2006
• IIE Industrial Engineer Logistics fix for the flu: time to look at curing supply chain ailments. March 2006
• Pharmaceutical Executive, February 2006 “Understanding Demand, Not Just Supply, Key to Solving Flu Vaccine Shortages”

• Manufacturing Chemist, February 2006 “Researchers offer logistics fix to flu outbreaks”
• El Heraldo de Aragon (Published in Spanish), January 2006 “Analisis del suministro de vacunas antigripales”
• BBC Radio 4, In Business and BBC Global Business Review, May 12, 2005

REPRESENTATIVE PUBLICATIONS:

• P. Yadav, K. Hanson, R. Smith. Role of Pharmaceuticals in Health Systems. Book chapter in Health Systems in Low- and Middle-Income Countries, Oxford University Press,  In Print.
• S. Kraiselburd and P. Yadav, Supply chains and global health: An imperative for bringing operations management scholarship into action, Production and Operations Management. In Print.
• Oliver Sabot, Prashant Yadav, Michel Zaffran. Maximizing Every Dose and Dollar: The Imperative of Efficiency in Vaccine Delivery, 2011 Impact and Innovation Series. The National Bureau of Asian Research.
• Prashant Yadav, Helen Lega Tata and Magali Babaley, Storage and Supply Chain Management, World Medicines Report, World Health Organization, 2011.
• Improving Public Health in Developing Countries through Operations Research, Invited Book Chapter, Encyclopedia of Operations Research and Management Science, Wiley & Co, NJ , 2010.
• P. Yadav. Countering Drug Resistance in the Developing World: An assessment of incentives across the value chain and recommendations for policy interventions, Center for Global Development, 2009.
• Increasing patient access to antiretrovirals: recommended actions for a more efficient global supply chain, with Paul Lalvani, Nandini Oomman, Michael Bernstein and Kirsten Curtis. Center for Global Development  2009.
• Levine, Ruth, J. Pickett, N. Sekhri Feachem and P. Yadav. “Demand Forecasting for Essential Medical Technologies.” American Journal of Law and Medicine, June 2008.

 Working papers:

• Prashant Yadav, Orla Stapleton and Luk N. Van Wassenhove, Always Cola, Rarely Essential Medicines: Comparing Medicine and Consumer Product Supply Chains in the Developing World INSEAD Working Paper No. 2010/54/TOM/INSEAD Social Innovation Centre.

• Examining the Role of CD4 Diagnostics in Reducing the Burden of HIV/AIDS in Resource-Limited Developing Countries. with M. Wagner and S. Finkelstein , Working Paper 2011, Earlier version in Proceedings of the XVIII AIDS Conference, Vienna.

• A Decision Framework for the Access Strategy of Medicines for Malaria Venture, Prashant Yadav, Luk Van Wassenhove and Orla Stapleton.

• Yadav, P, N. Sekhri, and K.A. Curtis, "Barriers to Access: An Assessment of Stakeholder Risks and Incentives in the Value Chain for Artemisinin Combination Therapy (ACT) Treatments".

• Prashant Yadav, James Riungu Mwenda, Olusoji Adeyi, Jessica Yip. Early effects of AMFm on retail price of Artemisinin-based Combination Therapies (ACTs) in Urban and Peri-urban Private Sector Outlets in Kenya.

 MANUSCRIPTS UNDER PREPARATION:

• J Friedman, M. Vledder, M. Sjoblom and P. Yadav. Improving Patient Access to Malaria and other Essential Medicines in Zambia: Results from a Large Scale Randomized Field Trial.

• J. Gallien, Z. Leung, A. Chen and P. Yadav. The Impact of Min/Max Ordering Rules on Malaria Drug Stock-outs in Sub-Saharan Africa: Lessons from a Field Experiment in Zambia.

• J. Gallien, Z. Leung, R. Davroux and P. Yadav. Design and Evaluation of an Inventory Control System for the Public Distribution of Essential Drugs in Zambia.

• T. Taylor and P. Yadav. Subsidizing the Distribution Channel: Donor Funding to Improve the Availability of Products with Benefit Externalities.

• Impact of Multiple First-line Therapies on Resistance and Supply Chain Costs in Resource Poor Settings, with Eirini Spiliotopoulou and Maciek Boni.

• What drives public-sector prices for pharmaceuticals in developing countries? with Richard Lai.

 TEACHING CASE STUDIES:

• When Supply is of Public Interest: Roche & Tamiflu, Noel Watson, Laura Rock Kopczak and Prashant Yadav, Harvard Business School Case # 9-609-061.

• Last Mile Logistics for Essential Drugs: The Case of Zambia, Prashant Yadav, Laura Rock Kopczak and Mark Roberts, Teaching Case, Harvard School of Public Health .

• Accessing the Inaccessible! Medicines for Malaria Venture, Prashant Yadav, Luk Van Wassenhove and Orla Stapleton, INSEAD Case  609-004-1.